Orthofix stock.

Orthofix appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release ...Orthofix Medical Inc. Stock technical analysis with dynamic chart and Delayed Quote | Deutsche Boerse AG: OM2 | Deutsche Boerse AGNov 28, 2023 · About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide. View the latest Orthofix Medical Inc. (OFIX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Orthofix Medical Stock Up 3.4 %. Shares of NASDAQ:OFIX opened at $11.19 on Tuesday. Orthofix Medical has a 1 year low of $9.57 and a 1 year high of $23.19. The company has a market cap of $411.31 million, a PE ratio of -2.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.58 and a quick ratio of …If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ...

(RTTNews) - Orthofix (OFIX) and SeaSpine (SPNE) have entered into a definitive agreement to combine in an all-stock merger of equals. SeaSpine shareholders will receive 0.4163 shares of Orthofix ...

Get a real-time Orthofix Medical Inc. (OFIX) stock price quote with breaking news, financials, statistics, charts and more.Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023. LEWISVILLE, Texas, October 18, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023 after market close.NEW YORK, NY / ACCESSWIRE / October 24, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …The shares of Orthofix Stock purchasable pursuant to the Plan may be authorized but previously unissued shares of Orthofix Stock or shares of Orthofix Stock held in treasury or purchased in the open market or in privately negotiated transactions. The Company shall bear all costs in connection with issuance or transfer of any shares and all ...

If you suffered losses exceeding $50,000 investing in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or ...

Orthofix International NV Stock price Nasdaq Equities ANN6748L1027 Medical Equipment, Supplies & Distribution Delayed Nasdaq. Other stock markets. 04:00:00 2018-08-02 pm EDT 5-day change 1st Jan Change ...

Jun 22, 2023 · Orthofix Medical's merger with SeaSpine has not significantly impacted investor sentiment or market expectations. See why we reiterate hold on OFIX stock. In most cases, there are no side effects to bone stimulation other than minor discomfort that occurs in rare instances, writes Orthofix. Numbness, tingling, headache and nausea may occur.13 hours ago · U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday. ... Orthofix Medical Inc. OFIX shares fell 5.4% to $10.52 in pre-market trading ... Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the M6-C ™ artificial cervical disc with anterior cervical discectomy and fusion (ACDF). Published in TheSpine Journal, patients treated with the M6-C disc ...5 de jan. de 2023 ... SeaSpine shares also ceased trading on the Nasdaq global market this morning. Holders of SeaSpine common stock will receive 0.4163 shares of ...

August 08, 2023 at 06:19 pm EDT. LEWISVILLE, Texas (AP) — LEWISVILLE, Texas (AP) — Orthofix Medical Inc. (OFIX) on Tuesday reported a loss of $39.4 million in its second quarter. On a per-share basis, the Lewisville, Texas -based company said it had a loss of $1.07. Earnings, adjusted for non-recurring costs and costs related to mergers and ...Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced Fitbone ™ TAA intramedullary limb-lengthening system has passed 5,000 devices implanted to date with more than 20 years of clinical history demonstrating safety and effectiveness in limb lengthening and deformity …August 08, 2023 at 06:19 pm EDT. LEWISVILLE, Texas (AP) — LEWISVILLE, Texas (AP) — Orthofix Medical Inc. (OFIX) on Tuesday reported a loss of $39.4 million in its second quarter. On a per-share basis, the Lewisville, Texas -based company said it had a loss of $1.07. Earnings, adjusted for non-recurring costs and costs related to mergers and ...3 analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 22.0% from the stock's current price.Orthofix Medical Inc. Enters into Financing Agreement with Blue Torch Finance LLC. Nov. 08. CI. Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q3 Revenue $184M, vs. Street Est of $185.8M. Nov. 08. MT. Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023.Orthofix Medical Inc. , a leading global spine and orthopedics company, today announced that it will host an Analyst Teach-In Meeting in Lewisville, TX on Monday, March 13, 2023 from 2:30 -...Find the latest Orthofix Medical Inc. (OM2.F) stock quote, history, news and other vital information to help you with your stock trading and investing.

The ownership structure of Orthofix (OFIX) stock is a mix of institutional, retail and individual investors. Approximately 86.20% of the company’s stock is owned by Institutional Investors, 2.18% is owned by Insiders and 11.62% is owned by Public Companies and Individual Investors. 2.18% Insiders.

17 de out. de 2023 ... Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next 30-90 days. Recent stocks from this ...Orthofix Medical has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript November 8, 2023 Orthofix Medical Inc. misses on earnings expectations. Reported EPS is $-0.77471 EPS, expectations were $-0.22. Operator: Hello. Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call.Orthofix Medical Inc. Stock technical analysis with dynamic chart and Delayed Quote | Deutsche Boerse AG: OM2 | Deutsche Boerse AGOrthofix’s stock has worst day in nearly 30 years after 3 top executives are fired for ‘offensive conduct’ (MarketWatch) Orthofix Medical Inc. investors suffered their worst day in nearly 30 years on Tuesday, after the spine and orthopedics company fired three top executives “for cause.”. The company OFIX, 2.31% said following an ...Orthofix Medical (NASDAQ: OFIX) is owned by 92.92% institutional shareholders, 13.59% Orthofix Medical insiders, and 0.00% retail investors. Cooper Robert Gaines is the largest individual Orthofix Medical shareholder, owning 1.53M shares representing 4.15% of the company. Cooper Robert Gaines's Orthofix Medical shares are currently valued at ...Jan 4, 2023 · As inducements to enter into employment with Orthofix and its subsidiaries following the merger with SeaSpine, Mr. Valentine, Mr. Bostjancic and Mr. Keran are respectively being granted restricted stock units that settle into 140,515; 35,128; and 35,128 shares of Orthofix common stock, and options to purchase 338,264; 84,566; and 84,566 shares ... 3 analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they predict the company's …

If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer …

Orthopedics. Orthofix offers innovative and minimally invasive extremity solutions to help surgeons improve their patient’s quality of life. Designed to address the lifelong bone and joint health needs of patients of all ages, our orthopedics products help patients achieve a more active and mobile lifestyle when compared to other surgical solutions. The ownership structure of Orthofix (OFIX) stock is a mix of institutional, retail and individual investors. Approximately 86.20% of the company’s stock is owned by Institutional Investors, 2.18% is owned by Insiders and 11.62% is owned by Public Companies and Individual Investors. 2.18% Insiders.Nov 29, 2023 · Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983 ... Orthopedics. Orthofix offers innovative and minimally invasive extremity solutions to help surgeons improve their patient’s quality of life. Designed to address the lifelong bone and joint health needs of patients of all ages, our orthopedics products help patients achieve a more active and mobile lifestyle when compared to other surgical solutions. Orthofix appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release ...Orthofix Medical has a market cap or net worth of $413.88 million as of November 29, 2023. Its market cap has increased by 23.58% in one year. ... is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding. Formula: Market Cap = Stock Price * Shares ...Compare OFIX With Other Stocks. Orthofix Medical Inc. develops, produces and markets medical devices. The Company offers spine fixation, biological and other orthopedic and spine solutions. Orthofix Medical Inc., formerly known as Orthofix International N.V., is headquartered in Lewisville, Texas. ORTHOFIX MEDICAL INC revenue from 2010 to 2023. About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today …

Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380.Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the M6-C ™ artificial cervical disc with anterior cervical discectomy and fusion (ACDF). Published in The Spine Journal, patients treated with the M6-C disc …Nov 28, 2023 · Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corporation (NYSE: ENOV). At that time, Mr. Calafiore is also expected to join ... Instagram:https://instagram. cryptocurrency is a bubblewhy is nvidia fallingavaveenasdaq ibkr Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript November 8, 2023 Orthofix Medical Inc. misses on earnings expectations. Reported EPS is $-0.77471 EPS, expectations were $-0.22. Operator: Hello. Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call.Orthofix Medical Inc. Stock price Deutsche Boerse AG Equities OM2 US68752M1080 Medical Equipment, Supplies & Distribution Market Closed - Deutsche Boerse AG. Other stock markets. 02:00:58 2023-11 … hydroponic cannabis growingamta vs abmp Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock? nysearca schh Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380.“Orthofix is a leader in both the demineralized bone matrices (DBM) and cellular allograft markets, and the launch of OsteoCove significantly strengthens our biologics portfolio and builds on our mission to deliver best-in-class products in every major bone grafting category,” said Tyler Lipschultz, President, Orthofix Global Biologics.